CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS
Aim of the study was to investigate the clinical features of reproductive age women with uterine body myoma and the production of vascular endothelial growth factor (VEGF) in the dominant myoma node and perifocal myometrium under the preoperative use of ulipristal acetate (UA). Material and methods....
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Siberian Branch Publishing House
2020-03-01
|
| Series: | Сибирский научный медицинский журнал |
| Subjects: | |
| Online Access: | https://sibmed.elpub.ru/jour/article/view/335 |
| _version_ | 1797269582744911872 |
|---|---|
| author | I. O. Marinkin L. A. Piven’ A. V. Volchek D. A. Solyanikov Yu. V. Zenina E. S. Mihaylova V. V. Omigov S. V. Aidagulova |
| author_facet | I. O. Marinkin L. A. Piven’ A. V. Volchek D. A. Solyanikov Yu. V. Zenina E. S. Mihaylova V. V. Omigov S. V. Aidagulova |
| author_sort | I. O. Marinkin |
| collection | DOAJ |
| description | Aim of the study was to investigate the clinical features of reproductive age women with uterine body myoma and the production of vascular endothelial growth factor (VEGF) in the dominant myoma node and perifocal myometrium under the preoperative use of ulipristal acetate (UA). Material and methods. 140 samples of 35 women surgical material were studied, VEGF content in the incubation medium of samples of myoma and myometrium was measured using enzymelinked immunosorbent assay.Results and discussion. The treatment by UA before myoma surgery according to the standard regimen per 5 mg daily for 13 weeks deals with significantly reduced production of VEGF in the dominant myoma node compared to perifocal myometrium (p < 0.001), which is similar to patients of the control group. However, when comparing tumor nodes, a significantly lower content of VEGF was revealed in the UA-group (p = 0.026); unlike the perifocal myometrium samples. Conclusion. The use of a selective modulator of progesterone receptors downregulates the production of VEGF by the cells of the myoma nodes and doesn’t impact on the perifocal myometrium. |
| first_indexed | 2024-03-08T14:33:47Z |
| format | Article |
| id | doaj.art-2ef5c2ab87494662a4558f18dd904e49 |
| institution | Directory Open Access Journal |
| issn | 2410-2512 2410-2520 |
| language | Russian |
| last_indexed | 2024-04-25T01:50:40Z |
| publishDate | 2020-03-01 |
| publisher | Russian Academy of Sciences, Siberian Branch Publishing House |
| record_format | Article |
| series | Сибирский научный медицинский журнал |
| spelling | doaj.art-2ef5c2ab87494662a4558f18dd904e492024-03-07T18:49:58ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202020-03-01401394410.15372/SSMJ20200105232CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORSI. O. Marinkin0L. A. Piven’1A. V. Volchek2D. A. Solyanikov3Yu. V. Zenina4E. S. Mihaylova5V. V. Omigov6S. V. Aidagulova7Novosibirsk State Medical University of Minzdrav of RussiaNovosibirsk State Medical University of Minzdrav of Russia, State Novosibirsk Regional Clinical HospitalNovosibirsk State Medical University of Minzdrav of Russia, State Novosibirsk Regional Clinical HospitalState Novosibirsk Regional Clinical HospitalNovosibirsk State Medical University of Minzdrav of RussiaNovosibirsk State Medical University of Minzdrav of RussiaNovosibirsk State Medical University of Minzdrav of RussiaNovosibirsk State Medical University of Minzdrav of RussiaAim of the study was to investigate the clinical features of reproductive age women with uterine body myoma and the production of vascular endothelial growth factor (VEGF) in the dominant myoma node and perifocal myometrium under the preoperative use of ulipristal acetate (UA). Material and methods. 140 samples of 35 women surgical material were studied, VEGF content in the incubation medium of samples of myoma and myometrium was measured using enzymelinked immunosorbent assay.Results and discussion. The treatment by UA before myoma surgery according to the standard regimen per 5 mg daily for 13 weeks deals with significantly reduced production of VEGF in the dominant myoma node compared to perifocal myometrium (p < 0.001), which is similar to patients of the control group. However, when comparing tumor nodes, a significantly lower content of VEGF was revealed in the UA-group (p = 0.026); unlike the perifocal myometrium samples. Conclusion. The use of a selective modulator of progesterone receptors downregulates the production of VEGF by the cells of the myoma nodes and doesn’t impact on the perifocal myometrium.https://sibmed.elpub.ru/jour/article/view/335uterine myomamyometriumvascular endothelial growth factorselective progesterone receptor modulatorenzyme immunoassay |
| spellingShingle | I. O. Marinkin L. A. Piven’ A. V. Volchek D. A. Solyanikov Yu. V. Zenina E. S. Mihaylova V. V. Omigov S. V. Aidagulova CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS Сибирский научный медицинский журнал uterine myoma myometrium vascular endothelial growth factor selective progesterone receptor modulator enzyme immunoassay |
| title | CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| title_full | CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| title_fullStr | CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| title_full_unstemmed | CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| title_short | CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| title_sort | clinical and histologic features of uterine myoma in reproductive age women under the treatment by selective progesterone receptor modulators |
| topic | uterine myoma myometrium vascular endothelial growth factor selective progesterone receptor modulator enzyme immunoassay |
| url | https://sibmed.elpub.ru/jour/article/view/335 |
| work_keys_str_mv | AT iomarinkin clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT lapiven clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT avvolchek clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT dasolyanikov clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT yuvzenina clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT esmihaylova clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT vvomigov clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators AT svaidagulova clinicalandhistologicfeaturesofuterinemyomainreproductiveagewomenunderthetreatmentbyselectiveprogesteronereceptormodulators |